2025 annual financial data
Bionano Genomics 2025 Net margin
Direct answer
Net margin was -92.59%.
Operating income was -33.34M USD and net income was -26.4M USD.
Operating cash flow was -16.35M USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28.51M USD
- Operating income
- -33.34M USD
- Net income
- -26.4M USD
- Operating cash flow
- -16.35M USD